Technology | PACS | January 06, 2017

Mirada Medical Highlights Molecular Imaging PACS Products at RSNA 2016

Latest version of XD:PACS helps integrate advanced nuclear imaging analysis into the enterprise

Mirada Medical, RSNA 2016, XD:PACS, molecular imaging, nuclear imaging

January 6, 2017 — Mirada Medical showcased its latest XD:PACS (picture archiving and communication system) range of molecular imaging products at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 1 in Chicago.

Mirada’s XD:PACS products are designed to empower radiology and nuclear medicine departments seeking to integrate advanced positron emission tomography (PET)/computed tomography (CT) reading, tumor tracking, single photon emission computed tomography (SPECT)/CT and nuclear medicine analysis into the enterprise. According to the company, XD:PACS products enable departments to dispense with the complexity and expense of having disparate legacy modality workstations and software packages.

The product range also includes the latest solutions for cardiology, neurology, radiation therapy and tumor board meetings. The software comprises flexible workflows and display protocols and results can always be saved for both editing and review on PACS.

For more information: www.mirada-medical.com

Related Content

Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
EchoPixel Showcases Next-Generation Surgical Planning With True 3-D Interactive Mixed Reality Software
News | Advanced Visualization | January 08, 2018
January 8, 2018 — EchoPixel showcased the latest version of True 3D, its interactive,...
Technology | PACS Accessories | January 03, 2018
January 3, 2018 — medQ Inc. recently announced the launch of its Q/ris MIPS Reporting module.
FDA Announces Final Guidance and Webinar for Technical Considerations for 3-D-Printed Medical Devices
News | 3-D Printing | January 03, 2018
The U.S. Food and Drug Administration (FDA) issued the final version of the guidance, “Technical Considerations for...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Philips Expands Population Health Management Business With Acquisition of VitalHealth
News | Population Health | December 28, 2017
Philips recently announced that it acquired VitalHealth, a provider of cloud-based population health management...
Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs
News | Lung Cancer | December 22, 2017
Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City...
News | Enterprise Imaging | December 21, 2017
Vital Images showcased enhancements to its enterprise imaging solutions at the Radiological Society of North America (...
Videos | Artificial Intelligence | December 21, 2017
ITN and DAIC Editor Dave Fornell shows several examples of how vendors are incorporating AI, deep learning algorithms
Overlay Init